GLP-1 - Health Rising

Stepping Backwards – the U.S.’s Attempt to Politicize Scientific Research: An Editorial

Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide

by Cort Johnson | Apr 6, 2026 | Abilify, Antivirals, Baricitinib, Bezisterim, CCR5 Antagonists, Drugs, GLP-1, Guanfacine, Homepage, Ivabradine, IVIG, JAK_STAT Inhibitors, Low Dose Naltrexone, Mestinon, Rapamycin, Stellate Ganglion Block, Stimulants, Trazodone, Treatment

Check out the The free RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide and why we may FDA approved drugs for long COVID quicker than you might think.

ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3

by Cort Johnson | Dec 4, 2025 | Baricitinib, Bezisterim, Brain, Cortene, Drugs, GLP-1, GLP-1 agonist, Homepage, HPA axis, Locus coeruleus, Low Dose Naltrexone, Neuroinflammation, Neuroinflammation, Neuroplasticity, Norepinephrine, Research, Suramin, Treatment

A Dutch ME/CFS autopsy report findings multiple severe problems in the HPA axis of ME/CFS patients.

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

by Cort Johnson | Nov 16, 2025 | Autonomic Nervous System, Brain, Brainstem, Clonidine, CoQ10, D-Ribose, GLP-1, GLP-1 agonist, Guanfacine, Homepage, Ivabradine, Kaiser, L-carntine/Acetylcarnitine, Locus coeruleus, Mast cell activation syndrome, Mestinon, Neuroplasticity, Neuroplasticity, Norepinephrine, Pacing, Prefrontal Cortex, Propanolol, Rapamycin, Research, Stimulants, Urolithin A

Check out how ChatGPT thinks people with ME/CFS and long COVID might treat the low norepinephine brain findings in these diseases.

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

by Cort Johnson | Nov 3, 2025 | COVID-19, Dempsey, Epstein-Barr Virus, GLP-1, Gut, Homepage, Immune, Inflammation, Kaufman, Mast cell activation syndrome, Mast cell activation syndrome, Neuroinflammation, Pathogens, POTS, RECOVER Initiative, Severe ME/CFS, Treatment

Complex, chronic illness experts discuss what GLP-1 agonists can and can't do in diseases like ME/CFS, long COVID, and POTS. Plus new long COVID trials.

RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations

by Cort Johnson | Oct 10, 2025 | Baricitinib, GLP-1, GLP-1 agonist, Homepage, Low Dose Naltrexone, NIH, Stellate Ganglion Block, Treatment

The RECOVER Initiative announces four more clinical trials for long COVID including low dose naltrexone, bariticinib, GLP-1 agonists, and stellate ganglion blockade.

The GLP1 Agonists: An Exciting New Class of Drugs For ME/CFS, FM and Long COVID?

by Cort Johnson | May 28, 2025 | GLP-1, Homepage, Inflammation, Kaufman, long COVID, Mast cell activation syndrome, Mast cell activation syndrome, Metabolism, Microbiome, Neuroinflammation, Ruhoy

GLP-1 agonists like Ozempic could be surprisingly helpful in diseases like chronic fatigue syndrome, fibromyalgia and long COVID.

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Homebound

ABC

Mount Vernon, United States

Total Economic Losses:

$257,601

Lives Interrupted Stats

Number of Stories: 48

Years of Work Lost: 349

Average Total Economic Losses:

$830,444

Total Economic Losses:

$29,065,530

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

A BIG thanks to everyone whose contributions helped make Health Rising's summer drive a success :)

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

Stepping Backwards – the U.S.’s Attempt to Politicize Scientific Research: An Editorial

Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide

ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway

RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations

The GLP1 Agonists: An Exciting New Class of Drugs For ME/CFS, FM and Long COVID?

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest